Logotype for Godfrey Phillips India Limited

Godfrey Phillips India (500163) Q2 24/25 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Godfrey Phillips India Limited

Q2 24/25 earnings summary

19 Nov, 2025

Executive summary

  • Consolidated gross sales value for H1 FY25 reached Rs 6,668 crore, up 23% year-over-year; net profit before exceptional items was Rs 522 crore, up 14% year-over-year.

  • Board approved unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2024, with limited review by auditors and no material misstatements found.

  • Robust domestic cigarette volume growth and strong unmanufactured tobacco exports supported topline performance.

  • Announced introduction of an Employee Share Purchase Scheme (ESPS 2024), subject to shareholder approval.

  • Initiated closure of the Retail Business Division (24Seven), with related exceptional loss recognized.

Financial highlights

  • Gross profit for H1 FY25 was Rs 1,122 crore with a margin of 16.8%; EBITDA stood at Rs 537 crore, up 12.8% year-over-year.

  • Standalone revenue from operations for Q2 FY25 was ₹164,885 lakhs, up from ₹137,574 lakhs in Q2 FY24.

  • Consolidated net profit for Q2 FY25 was ₹24,831 lakhs, up from ₹20,206 lakhs in Q2 FY24; H1 FY25 net profit was ₹47,686 lakhs.

  • Domestic gross sales value from tobacco was Rs 5,676 crore, contributing 98% to total gross sales.

  • International gross sales value was Rs 831 crore; retail business gross sales value was Rs 127 crore.

Outlook and guidance

  • Plans underway to enter new markets and launch new offerings, with a focus on sustaining growth momentum.

  • Strategic priorities include strengthening the core business, expanding international operations, and leveraging distribution partnerships.

  • Management reaffirmed the reasonableness of exceptional loss estimates related to the retail business exit.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more